PL3133083T3 - Wielostopniowa filtracja końcowa - Google Patents

Wielostopniowa filtracja końcowa

Info

Publication number
PL3133083T3
PL3133083T3 PL16188558T PL16188558T PL3133083T3 PL 3133083 T3 PL3133083 T3 PL 3133083T3 PL 16188558 T PL16188558 T PL 16188558T PL 16188558 T PL16188558 T PL 16188558T PL 3133083 T3 PL3133083 T3 PL 3133083T3
Authority
PL
Poland
Prior art keywords
final filtration
multistep
multistep final
filtration
final
Prior art date
Application number
PL16188558T
Other languages
English (en)
Inventor
Roberto Falkenstein
Klaus Schwendner
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of PL3133083T3 publication Critical patent/PL3133083T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/34Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Fats And Perfumes (AREA)
PL16188558T 2009-10-01 2010-09-29 Wielostopniowa filtracja końcowa PL3133083T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP09012460 2009-10-01
EP10757795.9A EP2483305B1 (en) 2009-10-01 2010-09-29 Multistep final filtration of immunoglobulin
EP16188558.7A EP3133083B1 (en) 2009-10-01 2010-09-29 Multistep final filtration
PCT/EP2010/064487 WO2011039274A1 (en) 2009-10-01 2010-09-29 Multistep final filtration

Publications (1)

Publication Number Publication Date
PL3133083T3 true PL3133083T3 (pl) 2020-09-07

Family

ID=41466840

Family Applications (2)

Application Number Title Priority Date Filing Date
PL10757795T PL2483305T3 (pl) 2009-10-01 2010-09-29 Wieloetapowa końcowa filtracja immunoglobuliny
PL16188558T PL3133083T3 (pl) 2009-10-01 2010-09-29 Wielostopniowa filtracja końcowa

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL10757795T PL2483305T3 (pl) 2009-10-01 2010-09-29 Wieloetapowa końcowa filtracja immunoglobuliny

Country Status (21)

Country Link
US (4) US20120231506A1 (pl)
EP (3) EP3133083B1 (pl)
JP (1) JP5458183B2 (pl)
KR (3) KR101508044B1 (pl)
CN (3) CN104610447A (pl)
AU (1) AU2010302662B2 (pl)
BR (1) BR112012004054B1 (pl)
CA (1) CA2773674C (pl)
CY (1) CY1118577T1 (pl)
DK (1) DK2483305T3 (pl)
ES (2) ES2787403T3 (pl)
HK (2) HK1200178A1 (pl)
HR (2) HRP20161693T1 (pl)
HU (1) HUE030186T2 (pl)
IL (2) IL217626A (pl)
LT (1) LT2483305T (pl)
MX (1) MX342442B (pl)
PL (2) PL2483305T3 (pl)
PT (1) PT2483305T (pl)
SI (2) SI3133083T1 (pl)
WO (1) WO2011039274A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3769083A1 (en) 2018-03-21 2021-01-27 Waters Technologies Corporation Non-antibody high-affinity-based sample preparation, sorbents, devices and methods
CN111007242A (zh) * 2019-12-20 2020-04-14 苏州和迈精密仪器有限公司 基于多层高分子多孔膜的荧光免疫检测方法、装置及应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643566A (en) 1982-09-23 1997-07-01 Cetus Corporation Formulation processes for lipophilic proteins
US4488961A (en) 1982-09-29 1984-12-18 E. I. Du Pont De Nemours And Company One-way filter unit
US4592848A (en) 1984-12-11 1986-06-03 Pabst Richard E Flow through filter with backflush clearing capability
CS247484B1 (cs) 1985-04-12 1987-01-15 Eva Hamsikova Způsob přípravy imunoglobulinu proti lidským Iymfocytům
JP3040121B2 (ja) 1988-01-12 2000-05-08 ジェネンテク,インコーポレイテッド 増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法
DE3818860A1 (de) 1988-06-03 1989-12-07 Seitz Filter Werke Filterelement
JP4124480B2 (ja) 1991-06-14 2008-07-23 ジェネンテック・インコーポレーテッド 免疫グロブリン変異体
DE4204444C1 (pl) 1992-02-14 1993-05-19 Krankenhausentsorgungs Gmbh, 1000 Berlin, De
DK1516628T3 (da) 1995-07-27 2013-09-08 Genentech Inc Stabil, isotonisk lyofiliseret proteinformulering
ES2335365T3 (es) 1996-11-27 2010-03-25 Genentech, Inc. Purificacion por afinidad de polipeptido en una matriz de proteina a.
DE69907439T3 (de) 1998-05-06 2014-01-02 Genentech, Inc. Reinigung von proteinen durch ionenaustauschchromatographie
US6984494B2 (en) * 2000-08-15 2006-01-10 Genentech, Inc. Analytical method
DE60325334D1 (de) 2002-02-05 2009-01-29 Genentech Inc Proteinaufreinigung
AU2003251592A1 (en) * 2002-06-21 2004-01-06 Biogen Idec Inc. Buffered formulations for concentrating antibodies and methods of use thereof
KR20050048666A (ko) * 2002-10-04 2005-05-24 기린 비루 가부시키가이샤 인간 인공 염색체(hac) 벡터
JPWO2004087761A1 (ja) 2003-03-31 2006-07-27 麒麟麦酒株式会社 ヒトモノクローナル抗体およびヒトポリクローナル抗体の精製
GB0316560D0 (en) * 2003-07-15 2003-08-20 Chiron Srl Vesicle filtration
CA2567814C (en) * 2004-05-27 2013-07-23 Jon A. Weidanz Antibodies as t cell receptor mimics, methods of production and uses thereof
PT1786273T (pt) * 2004-08-20 2019-02-19 The American Nat Red Cross Esquemas de isolamento e purificação de proteínas sequenciais por cromatografia de afinidade
US20060051347A1 (en) * 2004-09-09 2006-03-09 Winter Charles M Process for concentration of antibodies and therapeutic products thereof
US20080247949A1 (en) * 2004-11-22 2008-10-09 Oxygenix Co., Ltd. Biological Tissue Examination Agent Comprising Hemoglobin Labeled With Oxygen Isotope And Method For Producing The Same
TW200902555A (en) 2005-01-03 2009-01-16 Hoffmann La Roche Antibodies against IL-13 receptor alpha 1 and uses thereof
NZ560844A (en) * 2005-03-08 2008-08-29 Pharmacia & Upjohn Co Llc Anti-MAdCAM antibody compositions
WO2007018316A1 (ja) 2005-08-09 2007-02-15 Takeda Pharmaceutical Company Limited 癌の予防・治療剤
EP2078039B1 (en) * 2006-11-01 2017-09-13 Biogen MA Inc. Method of isolating biomacromolecules using low ph and divalent cations
JP5432137B2 (ja) * 2007-07-17 2014-03-05 エフ.ホフマン−ラ ロシュ アーゲー 可変的タンジェンシャルフロー濾過
AR067536A1 (es) 2007-07-17 2009-10-14 Hoffmann La Roche Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea
WO2009058769A1 (en) 2007-10-30 2009-05-07 Schering Corporation Purification of antibodies containing hydrophobic variants
EP2346900A1 (en) 2008-10-29 2011-07-27 Wyeth LLC Methods for purification of single domain antigen binding molecules
SI2914612T1 (sl) * 2012-10-30 2019-03-29 F. Hoffmann-La Roche Ag Čiščenje polipeptidov z uporabo dvostopenjske tangencialne ultrafiltracije

Also Published As

Publication number Publication date
LT2483305T (lt) 2016-11-25
CA2773674C (en) 2017-08-29
KR101653471B1 (ko) 2016-09-01
CY1118577T1 (el) 2017-07-12
KR20160104739A (ko) 2016-09-05
IL217626A (en) 2017-12-31
PL2483305T3 (pl) 2017-03-31
HK1200178A1 (en) 2015-07-31
ES2787403T3 (es) 2020-10-16
ES2604103T3 (es) 2017-03-03
CN103980346A (zh) 2014-08-13
DK2483305T3 (en) 2016-10-24
HK1210183A1 (en) 2016-04-15
CA2773674A1 (en) 2011-04-07
IL255658A (en) 2018-01-31
AU2010302662B2 (en) 2015-11-26
BR112012004054A2 (pt) 2020-08-11
CN104610447A (zh) 2015-05-13
JP2013505733A (ja) 2013-02-21
US20120231506A1 (en) 2012-09-13
US20200291097A1 (en) 2020-09-17
KR20140091763A (ko) 2014-07-22
EP2483305B1 (en) 2016-09-21
BR112012004054B1 (pt) 2021-09-08
KR101718301B1 (ko) 2017-03-20
HUE030186T2 (en) 2017-04-28
JP5458183B2 (ja) 2014-04-02
EP3133083B1 (en) 2020-02-19
CN102574913A (zh) 2012-07-11
KR20120053522A (ko) 2012-05-25
SI2483305T1 (sl) 2017-01-31
MX342442B (es) 2016-09-29
US11891430B2 (en) 2024-02-06
KR101508044B1 (ko) 2015-04-07
US20180009878A1 (en) 2018-01-11
MX2012003727A (es) 2012-04-30
SI3133083T1 (sl) 2020-07-31
AU2010302662A1 (en) 2012-02-09
EP2483305A1 (en) 2012-08-08
PT2483305T (pt) 2016-11-04
HRP20200588T1 (hr) 2020-07-10
EP3715369A1 (en) 2020-09-30
US20240132574A1 (en) 2024-04-25
HRP20161693T1 (hr) 2017-02-24
WO2011039274A1 (en) 2011-04-07
EP3133083A1 (en) 2017-02-22

Similar Documents

Publication Publication Date Title
GB201103481D0 (en) No details
GB201016096D0 (en) No details
GB201016097D0 (en) No details
GB0900138D0 (en) Filtering speech
GB0904558D0 (en) Membranes
PL2275187T3 (pl) Układ filtrowania
PL2387446T3 (pl) Kombinacyjny filtr
HK1169669A1 (en) Concatamers for immunemodulation
HK1163368A1 (en) Filter arrangement
GB0922659D0 (en) Factor H
GB2468770B (en) Drainage arrangement
IL255658A (en) Multi-stage final filtering
GB0916769D0 (en) Water filter
GB201006421D0 (en) Filter
HU0900073V0 (en) Water filter
GB0910950D0 (en) Filtration
GB0914067D0 (en) Filter means
GB2470588B (en) Drawing aid
GB0921794D0 (en) Can final removal
GB0900587D0 (en) Can final removal
GB0917632D0 (en) Filter
GB0917567D0 (en) Filter
GB0914267D0 (en) Waterpoint filter
TWM385400U (en) water filter
GB201009139D0 (en) Reminder